Description

Sodium Glucuronic Acid, the sodium salt of D-glucuronic acid, enhances hepatic detox pathways by binding toxins to form glucuronides, promoting safe excretion. It helps increase liver glycogen, reduce lipolysis, and protect against liver injury induced by toxins or diseases such as chronic hepatitis and cirrhosis. The sterile injection form allows for precise dosing in preclinical hepatoprotection studies.

Product Specifications

Mechanism of Action

Sodium glucuronate is converted into glucuronic acid, which conjugates toxins via glucuronidation, enhancing renal/biliary excretion. It also helps preserve liver glycogen and suppress lipolysis, thus aiding detox and liver cell protection.

Research Application Areas

• Preclinical models of acute and chronic hepatitis

• Cirrhosis and hepatic fibrosis protection studies

• Detoxification and toxin-binding assays

• Oxidative stress mitigation in liver injury models

• Enhancement of glucuronidation pathway biomarker research

Safety & Handling

• Dosage in Animal Models: IM or IV at 0.133–0.266?g per injection, administered 1–2× daily

• Adverse Effects: None reported in clinical use

• Contraindications: Hypersensitivity to the compound

• Storage: Keep sealed, avoid high temperatures and light exposure

• Handling: Use PPE; ensure sterility

Core Keywords

sodium glucuronate injection, sodium glucuronic acid injection, CAS 14984-34-0, glucuronide hepatoprotection, H37023334, detox liver injection, research-grade glucuronate, wholesale sodium glucuronate, lab hepatoprotective agent

Research Use Disclaimer

This product is intended exclusively for laboratory and preclinical research. It is not approved for clinical, therapeutic, diagnostic, or veterinary use. Misuse may have legal or health implications. Use only under appropriate institutional protocols.